Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...

Fact checked by Nick Blackmer By 2060, nearly 14 million Americans may be living with Alzheimer’s disease. We still don’t ...

Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections ...

This essay is adapted from his upcoming book, “Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s.” Jan. 24, 2025 Medical advances have beaten back many relentless ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...